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1
METHOD FOR OBTAINING ANTIFUNGAL
AND HERBICIDAL COMPOUNDS THAT
TARGET THE FIRST COMMITTED STEP IN
SHINGOLIPID LONG-CHAIN BASE
BIOSYNTHESIS

-continued
The route of sphingolipid biosynthesis is proposed to be:

5
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NR2

2% 3~ketodihydrosphingosine

This application is a continuation of application Ser. No.
07/906,899 ?led Jun. 30, 1992, now abandoned.

+

CO2
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b. 3 -keto dihydrosphingo sine

CoASH

CH3(CH2)14(|:H — (‘1H — CHZOH

%

BACKGROUND OF THE INVENTION

+

OH NH;

dihydrosphingosine
+

1. Field of the Invention
This invention relates to the isolation of the LCBl and
LCB2 genes of the year Saccharomyces cervisiae that
encode subunits of the enzyme serine palmitoyltransferase

+

NADPH

NADP+

+

H‘r

O , ?

c. dihydrosphingosine —2———> phytosphingosine

(SPT), the ?rst enzyme leading to synthesis of the long~base

cl. long-chain base
ceramide
+
—>>
+

component of sphingolipids. The invention further relates to
method of using these genes to either inhibit SPT activity or
to inhibit synthesis of the enzyme. Furthermore, the inven

fatty acyl-CoA

CoA

Reaction (a), the ?rst committed step in sphingolipid
tion relates to methods for construction strains of S. cervi
biosynthesis (reviewed in Merrill, A. H. and Jones, D. D.
siae or other organisms that can be used to select and test for
1990. Biochemica et Biophysica Acta. 1044:1—12) is cata
compounds that either inhibit SPT activity or to inhibit 25 lyzed by serine palinitoyltransferase (SPT, also called 3-ke

synthesis of the enzyme.
2. Description of the Background
Sphingolipids are abundant in the membranes of fungi
(Brennah, P. 1., & Losel, D. M. 1978. Fungal lipids, in
Microbial Physiology, Rose, A. H. & Morris, P. G., Eds. 17,
47—179, Acad. Press.,,N.Y.), animals (Seeley, C. C. and
Siddiqui, B. 1977; the Glycojungates, Horowitz, M. I. and

30

todihydrosphingosine synthetase). This enzyme has been
shown to occur in the fungus Hansenula ciferri (Snell, E. E.,
Di Mari, S. 1., and Brady, R. N. 1970. Chem. Phys. Lipids,
5:116~138), in beef liver (Stolfel, W. 1970. Chem. Phys.
Lipids. 51 139-158), and in the bacterium Bacteroides mela
ninogenicus (Lev, M., and Milford, A. F. 1973. Arch. Bio
chem. Biophys. 157:500-508). Other evidence for this reac
tion comes from our own work in S. cervisiae (Pinto et al.,

Pigman, W., eds., Acad. Press, N.Y. 1:495), and higher plants

1986; Pinto W. 1., Wells, G. W. and Lester, R. L. 1992. J.

(Laine, R. a., Hsieh, T. C.-Y., & Lester, R. L. Glycophos

Bacteriol. 174:2575-2581). The enzyme has never been

phocerarnides from plants, in Cell Surface Glycolipids, p.65,

purified to homogenity and characterized in any detail
(reviewed in Merrill, A. H. and Jones, D. D. 1990. Bio
chemica et Biophysica Acta. 1044:1-12).
In reaction (d) the long-chain base is attached to a fatty

Am. Chem. Soc. Symp. Ser. 128, Am. Chem. Soc. Wash,
DC.) 1980. In spite of much e?ort, it has been dif?cult to
understand the exact biological role(s) of sphingolipids and
their mode of action at the molecular level. In animals,
sphingolipids are thought to play a role in such general
cellular events as cell-to-cell recognition, regulation of cell

acid to form a cerarnide. In all organisms ceramides are

converted to complex derivatives, the sphingolipids, by the
addition of polar groups to the l-hydroxyl. The sphingolip
ids in animals contain various oligosaccharides inked gly
growth, and diiferentiation. The prevalence of sphingolipids
suggests that they play vital roles in cells and direct proof 45 cosidically to the cerarnide to yield glycosphingolipids and
also contain choline linked by a phosphodiester bond to
that sphingolipids are essential cellular components has been
ceramide to yield the abundant compound sphingomyelin.
obtained with the discovery of mutants of S. cervisiae that
Certain sphingolipids in fimgi and plants differ from the
absolutely require a sphingolipid long-chain base (see
sphingolipids in animals because the l-hydroxyl is linked
below) for growth (Wells, G. B. and Lester, R. L.; J.Biol.
Chem. 258: pages 10200-10203 (1983)) and viability 50 through a phosphoryl group to inositol (myo-inositol) rather
than directly to a sugar. This core structure, inositol-phos
(Pinto, W. J ., Wells, G. B., Williams, A. C., Anderson, K. A.,
phorylcerarnide, or inositol-P-ceramide (“IPC”, Smith, S.
Teater, E. C., and Lester, R. L., Fed. Proc. 45: 1826 (1986)).
W., and Lester, R. L. 1974. J. Biol. Chem. 249:3395-3405),
sphingolipids are derivatives of ceramides containing
along with mannose-inositol-P-ceramide, (MIPC, ibid) and
sugars and sometimes phosphates. Cerarnides usually con 55 mannose-(inositol-P)2-ceramide (M(IP)2C, (Steiner, S.,
tain a fatty acid of 20-26 carbons connected via an amide

Smith, S. Waechter, C. J ., and Lester, R. L. 1969. Proc. Natl.

linkage to a long-chain base. The major long-chain bases

Acad. Sci. USA. 64:1042—1048) collectively constitute the
sphingolipids in S. cervisiae (Smith, S. W., and Lester, R. L.
1974. J. Biol. Chem. 249:3395-3405). Phosphoinositol sph
ingolipids are also a major class of lipids in plants (for

and their predominant distribution are:
Sphingosine (animals)

CH3(CH2)12CH=CH—CH—CH—CH;OH
OH NH;

references see Kaul, K. and Lester, R. L. 1975. Plant

Physiol, 55:120—129) and parasites (Singh, B. N., Costello,
C. E., and Beach, D. H. 1991. Arch. Biochem. Biophys.

Phytosphingosine (plants, fungi)

CH2(CH2)12"CHz—CH—$H-—$H—CH2OH
OH OH NH;

286:409-418).
65

Because sphingolipids are vital for S. cerevisiae, the
long-chain base biosynthesis pathway would appear to be a

good target for antifungal compounds. In fact, sphingolipids

5,583,030
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may be vital for all organisms that contain them, and
therefore, any compound that would inhibit long-chain base
biosynthesis might inhibit growth of an organism that con

FIG. 6 sets forth the DNA sequence of the LCB2 (SEQ ID

NOS.: 4-6) gene and the predicted protein sequence.
FIG. 7 sets forth a comparison of LCB1 (SEQ ID NOS.:

tained sphingolipids.

l-3), LCB2 (SEQ ID NOS.: 4-6), and the S. cerevisiae
HEMl protein sequences.

Accordingly, there is a need to begin to identify or design

such inhibitory antifungal compounds to target the long
chain base biosynthesis pathway, which would appear to be
a good target for antifungal compounds. Therefore we
isolated two S. cerevisiae genes, LCB1 (SEQ ID NOS.: 1-3)
and LCB2 (SEQ ID NOS.: 4-6), that most likely encode

DESCRIPTION OF THE PREFERRED
EMBODIMENTS
10

subunits of SPT. These are the ?rst genes involved in

long-chain base biosynthesis to be isolated from any organ
ism. The genes provide a unique opportunity to identify
compounds that block SPT activity or synthesis in speci?c

having a nucleotide sequence as set forth in FIG. 2. It also

organisms.
SUMMARY OF THE INVENTION

One objective of the present invention is to provide the
LCB1 (SEQ ID NOS.: l-3), and the LCB2 ((SEQ ID NOS.:
4-6) genes of S. cerevisiae and to demonstrate that they
provide SPT enzyme activity to a strain that lacks such

20

enzyme activity.
Another objective of the present invention is to provide
the LCB1 ((SEQ ID NOS.: 1-3), and the LCB2 ((SEQ ID

25

NOS.: 4-6), genes of S. cerevisia for use in constructing a

genetically engineered strain of S. cerevisiae that has
increased SPT protein and therefore enzyme activity.
Another objective of the present invention is to provide
the DNA sequence of the LCB1 ((SEQ ID NOS.: 1-3) and
LCB2 ((SEQ ID NOS.: 4-6) genes for use as targets for
antisense or triple-helix~forming oligonucleotides which

35

40

sequence.
In another embodiment the present invention provides a

host cell line transformed by a plasmid containing the LCB2
(SEQ ID NOS.: 4-6) sequence according to the present
invention.
The present invention further provides a genetically engi
neered strain of S. cerevisiae which has increased production
of Serine Palmitoyltransferase protein and therefore
increased enzyme activity as compared to the wild type S.
cerevisiae.
In another aspect the present invention provides an anti
sense or triple helix forming oligonucleotide speci?c for the
LCB1 (SEQ ID NOS.: l-3) sequence, which will inhibit the
In still another aspect the present invention provides an

50

antisense or triple-helic-forming oligonucleotide speci?c for
the LCB2 (SEQ ID N08.: 4-6) sequence, which will inhibit

the production of Serine Palrnitoyltransferase protein.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 represents a schematic diagram of plasmids car
rying the LCB1 (SEQ ID NOS.: 1-3) gene of S. cerevisiae.
FIG. 2 sets forth the DNA sequence of the LCB1 (SEQ ID

55

NOS.: 4-6) gene and the predicted protein product.
lyze a chemical reaction that is similar to the one catalyzed

60

enzyme.

Also the present invention provides a method for testing
an oligonucleotide or organic compound for the ability to
block Serine Palmitoyltransferase activity or synthesis,

by SPT.
FIG. 4 sets forth a comparison of the reaction catalyzed by
I

FIG. 5(A-C) represents a schematic diagram of plasmids
carrying the LCB2 (SEQ ID NOS.: 4-6) gene of S. cerevi

The present invention also provides a genetically engi~
neered microbial strain transformed by a plasmid compris
ing either the LCB1 (SEQ ID NOS.: l-3) or LCB2 (SEQ ID
NOS.: 4-6) sequence, or both the LCB1 (SEQ ID NOS.:
l-3) and LCB2 (SEQ ID NOS.: 4-6) sequences, which
overexpresses the gene(s) with which it is transformed and

subsequently overproduces the Serine Palrnitoyltransferase

FIG. 3 sets forth a comparison of the ‘LCB1 (SEQ ID

NOS.: 1-3) protein sequence with other proteins that cata

siae or portions of the gene.

comprising the LCB2 (SEQ ID NOS.: 4-6) sequence
according to the invention. Particularly preferred is a plas
mid according to the invention which is the plasmid

production of Serine Palrnitoyltransferase protein.

NOS.: 4—6)-defective strain, respectively.

SPT and other enzymes.

In another embodiment the present invention provides a
host cell line transformed by a plasmid containing the LCB1
(SEQ ID NOS.: l-3) sequence according to the present
invention.
In another aspect the present invention provides a DNA
sequence LCB2 (SEQ ID NOS.: 4-6) having a nucleotide

pRSLCB2-2 containing the LCB2 (SEQ ID NOS.: 4-6)

sequence. The genes are shown to restore SPT activity to a

lcbl((SEQ ID NOS.: l-3)-defective and lcb2((SEQ ID

provides a plasmid comprising the LCB1 sequence accord
ing to the invention. Particularly preferred is a plasmid
according to the invention which is the plasmid pTZl8
LCB1 (SEQ ID NOS.: l-3) containing the LCB1 (SEQ ID
NOS.: 1-3) sequence. Also, particularly preferred is a plas
mid according to the invention which is plasmid YIpLCBl-l
containing the LCB1 sequence.

sequence as set forth in FIG. 6. It also provides a plasmid
30

will inhibit the production of SPT protein.
Another objective of the present invention is to provide
the DNA sequence of the LCB1 (SEQ ID NOS.: l-3) and
LCB2(SEQ ID NOS.: 4-6) genes for use in overexpression
of the genes and subsequent overproduction of the SPT
enzyme.
Another objective of the present invention is to provide
the DNA sequence of the LCB1 ((SEQ ID NOS.: l-3) and
LCB2 ((SEQ ID NOS.: 4-6) genes for use in isolating the
homolog of these genes from other organisms.
Other objectives and advantages of the invention will
become apparent as the description thereof proceeds.
In satisfaction of the foregoing objects and advantages,
the present invention provides the LCB1 ((SEQ ID NOS.:
l-3) and LCB2 ((SEQ ID NOS.: 4-6) genes and their DNA

The invention relates to the isolation of the LCB1 (SEQ
ID NOS.: l-3) and LCB2 (SEQ ID NOS.: 4-6) genes of S.
cerevisiae.
The present invention provides a DNA sequence LCB1

65

which method comprises:
exposing the oligonucleotide or the organic compound
being tested to a host cell or host cell extract, which host cell
has been transformed to include either a LCB1 (SEQ ID

5,583,030
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NOS.: l-3) gene or LCB2 (SEQ ID NOS.: 4-6) gene (or

strain W303-1B (MATot ade2-l canl-lOO ura3-l his3-l1,l5
trpl-l leu2-3,1l2; obtained from R. J. Rothstein, Columbia

both genes), and
testing for an absence of Serine Palmitoyltransferase
enzyme or its activity, which diminished activity is indicated
by the absence or lower concentration of sphingolipids.
The present invention further provides an oligonucleotide
DNA sequence, which is a complement to either the LCB1

University). Progeny from this cross were backcrossed to
W303-1B, and several o?spring were selected for further

(SEQ ID NOS.: 1-3) or LCB2 (SEQ ID NOS.: 4-6)

the LCB1 allele with a mutant allele that was disrupted by
inserting a 1.1-kb URA3 DNA fragment at the SalI site of

study, including strains X2A1B (MATa lcbl-1 ura3-l trpl-l
his3-11,15). Strain SL1 was derived from strain SJ21R

(MATa ura3-52 leu2-3,ll2 adel MELl) by replacement of

sequences, or to portions thereof.

In yet another aspect the present invention provides a

10

LCB1. The LCB1: URA3-disrupted allele was prepared by

transferring 4.3-kb HindIII-Stul fragment, carrying LCB1,
from pLCB to pTZ18 (Pharmacia) cleaved with HindIII and
Smal. The resulting plasmid, pTZl 8-LCB1 was cleaved

method of testing for and/or isolating closely related
sequences (similar to LCB1 (SEQ ID NOS.: 1-3)) which

comprises
producing or obtaining an oligonucleotide which is a
complement to a portion of the LCB1 (SEQ ID NOS.: 1-3)
gene, and

with SalI and ligated with a 1.1-kb URA3 DNA fragment
having SalI cohesive ends (obtained from pUC-URA3 cut

using the complement as an oligonucleotide probe by

To replace the LCB1 chromosomal allele with the URA3
disrupted allele, 10 pg of pTZ18-LCB1::URA3 DNA was
cleaved with Xbal and ClaI, extracted with phenol, phenol
chloroform, and chloroform and precipitated with ethanol.

with SalI) to yield pTZ18-LCB1::URA3.

‘ exposing a target nucleotide sequence to the said nucle

otide probe and testing for binding to said probe, and
20

optionally

The DNA was transformed into strain SJ21R with selection

isolating and separating the nucleotide probe from the

for Ura+ transformants. Replacement of the LCB1 chromo
somal allele with the URA3-disrupted allele was veri?ed by

DNA sequence to which it has bound.

In still another aspect, the present invention provides a
method of testing- for and/or isolating closely related
sequences (similar to LCB2 (SEQ ID NOS.: 4-6)) which
comprises

Southern blot analysis. YIpLCBl-l was constructed by
25

_

inserting TRPl of S. cerevisiae, as a 1.4-kb HindIII frag
mentm into the HindIII site of pTZl8-LCB1. YIpLCBl-l

was cleaved at its unique BAMHI site located on the 3'side
of
LCB1, and the linear DNA was used to transform strain
complement to a portion of the LCB2 (SEQ ID NOS.: 4-6)
24D5 with selection for Ura+transformants. Integration at
gene, and
30 the expected chromosomal location was veri?ed by South

producing or obtaining an oligonucleotide which is a

using the complement as an oligonucleotide probe by

ern blotting. Transformants were crossed to strain YPHl

exposing a target nucleotide sequence to the said nucle

(MATa ura3-52 lys2-80l ade2-l0l (See, for example,

otide probe and testing for binding to said probe, and

Genetics, 122, 19-27 (1989)).

optionally
isolating and separating the nucleotide probe from the

35

DNA sequence to which it has bound.

The LCB1 (SEQ ID NOS.: 1-3) and LCB2 (SEQ ID
NOS.: 4-6) sequences according to the present invention,
plasmids comprising either of the LCB1 (SEQ ID NOS.:
1-3) or LCB2 (SEQ ID NOS.: 4-6) sequences, transformed
host cells having a sequence according to the present inven
tion, and sequences which are complements are all useful in

vector was pBR322 with a 0.63-kb Sau3A CEN3 DNA
fragment inserted into the PvuII site of the vector and a

1.4-kb TRTRPl ARSl fragment inserted into the EcoRI site
of the vector. The ligations were done with molecules whose
40 ends were made blunt ended so that the original restriction

sites were destroyed. Sau3A genomic DNA fragments of
8-kb average size from strain X2180 (a/ot gal2/gal2) were
cloned into the BamHI site of the vector (the library was

screening potential antifungal agents, or for producing
reagents useful in screen potential antifungal agents, (both
oligonucleotides and organic chemical agents, which are

The plasmid pLCB was isolated from a S. cerevisiae
genomic DNA library carried in a CEN vector. The 6.44-kb

obtained from ZymoGenetics, Seattle, Wash). DNA frag
45

potential antifungal agents may be screened).

ments from pLCB were subcloned into YCpSO (see, Meth

ods Enzymol, 152, 481-504 (1987)).

The sequences according to the present invention are also

Plasmids were propagated in Escherichia coli DH50t. The
lob-defective strains were propagated in several media as
described later in the detailed section which follows.

useful to provide oligonucleotides which have complemen
tary DNA sequences, which complementary sequences can
be used as probes to screen for sequences which are

For example, to isolate LCB1, strain X2A1B (relevant
genotype lcbl-1, trpl) was transformed with a genomic

homologs of the claimed sequences and/or used in a process

to isolate and ultimately sequence such homologs of LCB1
(SEQ ID NOS.: 1-3) or LCB2 (SEQ ID NOS.: 4-6).
In accordance with present invention, as a preliminary
step, a mutant strain of S. cerevisiae blocked in sphingolipid

DNA library which was carried in a vector containing CEN3

biosynthesis was obtained. For example, strains of S. cer
evisiae carrying the mutant allele, lcbl-1, are absolute

selected on minimal medium plates containing phytosphin
gosine but lacking tryptophan. Transformants were pooled

auxotrophs and grow only when a long-chain base (lcb,
phytosphingosine but not sphingosine) is added to the cul

and ARSl, for single-copy propagation in yeast cells, and
TRPl, for selection of Trp+ yeast that had been transformed
with the vector. Ten thousand Trp+ transforrnants were

60

and reselected on minimal medium plates lacking both
tryptophan and phytosphingosine. About one per thirty-?ve

ture medium.
The genes were isolated from a S. cerevisiae genomic

hundred Trp+ colonies was able to grow without added

DNA library by complementation for growth on medium

Plasmid DNA was isolated from several Lcb+ yeast trans
forrnants and transformed into E. coli with selection for
ampicillin resistant cells. Plasmid DNA from E. coli trans
formants was isolated and digested with restriction endonu

lacking a long-chain base (such as phytosphingosine) of an
lcbl or an lcb2-defective Strain.

The original lcb mutant MCGA (MATot lcbl-1 inol (J.
Biol. Chem. 258, 10200-10203 (1983) was crossed with

phytosphingosine and thus had an Lcb‘” phenotype.

cleases. The pattern of restriction fragments indicated that

5,583,030
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the original Lcb’" yeast transforrnants all contained the same
plasmid which carried an insert of about 8 kb.
To localize the LCB1 gene on the 8 kb DNA insert we
subcloned parts of the insert into the CEN4 vector YCp50
and tested the resulting plasmids for their ability to confer a
Lcb+ phenotype on strain X2A1B. The experiments local
ized LCB1 to a subclone of 4.0 kb (FIG. 1).
Further localization of LCB1 was achieved by chromo
somal disruption. For these experiments the 4 kb insert was

1 was subjected to DNA sequence analysis and the sequence

was analyzed by computer to locate large open reading
frames which could encode the LCB1 protein. The sequence

(FIG. 2) contained a single, large open reading frame,
encoding 558 amino acids which was oriented in the same
direction of transcription as the LCB1 mRNA (data not

shown). This region must code for the LCB1 protein product
because it is in the correct 5’ to 3' orientation, because a

URA3 disruption of the open reading frame at the unique
SalI site created a Lcb‘ phenotype, and because it is geneti
cally tightly linked to the lcbl-l allele.

disrupted at the unique SalI site (FIG. 1) by insertion of the
URA3 gene of S. cerevisiae to create the lcbl::URA3

The nucleotide sequence of the open reading frame was
used to product the anrino acid sequence of the LCB1
peptide. The results of the prediction are illustrated above

disruption allele. The lcb1::URA3-disruption allele was
used to replace the wild type LCB1 allele in strain SJ 21R

(relevant phenotype Lcb+ Ura‘) by homologous recombina
tion as described in EXAMPLE 2. These procedures pro

duced a strain, SL1, having the chromosome disrupted at the
expected SalI site. If this procedure had disrupted the LCB1
gene then the strain SLlshould require long-chain base

(phytosphingosine) for growth and, therefore, having an
Lcb“ phenotype. This expectation was veri?ed because
strain SL1 had an Lcb‘ phenotype. We conclude that the SalI
site shown in plasmid YCpSO-LCBl between the PstI and
Hpal sites is located within the LCB1 gene.
Genetic complementation analysis was used to verify that
the lcb1::URA3 disruption mutation in strain SL1 was allelic
to the original lcbl-l mutation carried in strain X2A1B.
Strain SL1 was crossed to strain 24D5. The resulting dip
loids had an Lcb‘ phenotype, suggesting allelism of the
cloned gene and lcbl. Strong support for allelism would be

obtained by sporulating these diploids and showing that all
tetrads give four Lcb‘ spores. However, such diploids failed
to sporulate under a variety of conditions suggesting that
sphingolipids are needed for sporulation. An alternative
genetic approach was used to demonstrate allelism. The
putative LCB1 allele, carried on the integrating vector
YIpLCBl-l, was directed to integrate into its homologous

20

25

30

LCB1 protein is —l.39, a value that places the protein in the
same class as globular proteins. A globular, rather than
35

integral membrane, protein is also predicted by the proce
dure of Eisenberg, D., Schwartz, E., Komaromy, M., and
Wall, R. 1984. J. Mol. Biol. 179:125-142. In addition, this

analysis predicts two very hydrophobic, membrane-associ
ated helices. Helix I spans amino acid residues 12—32 and

has the sequence IPIPAFIVTTSSYLWYYFNLV, while
Helix II spans residues 344-373 and has the sequence

ATAIDITVGSMATALGSTGGFVLG.

45

The predicted amino acid sequence of the LCB1 protein
shows high similarity to the enzyme S-aminolevulinic acid
synthase (ALA synthase) whose structural gene has been
sequenced from many organisms including S. cerevisiae

(ALSY (SEQ ID NO.: 12), FIG. 3, Urban-Grimal, D.,
Wollard, C., Garnier, T., Dehoux, P., and Labbe-Boise, R.

as claimed.

50% of the wild-type level since three independent trans
formants of strain X2A1B gave 22.7, 25.6, and 22.8 units of
enzyme activity per mg of protein. These data support the

spanning regions. According to the 5theory of Kyte, J ., and
Doolittle, R. F. 1982. J. Mol. Biol. 157:105—132, the Grand

Average Hydropathy Score (GRAVY) for the predicted

lcbl-l and there should be little if any recombination events

carried in pLCB was able to restore enzyme activity to about

Because SPT activity is present in the membrane fraction
of lysed cells, we expected the LCB1 protein to be mem
sequence was therefore exarrrined for potential membrane

strain for integration of YIpLCBl was strain 24D5 which
carried the lcbl-1 mutation. If YIpLCBl-l did indeed carry
the wild type LCB1 gene then the host strain should have
this plasmid integrated next to the lcbl-1 allele. When this
strain is crossed to an LCB1 strain (YPHl) all progeny
should be Lcb+ since YIpLCB l-l should be tightly linked to

To determine if SPT activity was missing in lcbl-defec
tive strains and to determine if a plasmid carrying LCB1
restored such activity we assayed membranes for the
enzyme. The parental strain MC6A contained 54.4 units of
enzyme activity per mg of protein while the lcbl-defective
strain X2A1B contained 2.5 units per mg of protein or about
20 times less enzyme activity that the parental strain: this
level of activity is at the limit of detection and the actual
enzyme activity may be lower. The cloned LCB1 allele

processing or because an ATG codon down stream of the one
shown in FIG. 3 is used as the initiation codon.

brane~associated. The hydrophobicity of the deduced protein

chromosomal locus as described in EXAMPLE 3. The host

that would separate the two alleles. In fourteen four-spored
tetrads from such a cross, showing 2*:2‘ segregation for the
Ade, Ura and Leu phenotypes, all spores were Lcb+ indi
cating that YIpLCBl had been directed to integrate in close
proximity to the lcbl-1 allele. We conclude that the LCB1
gene has been cloned and is carried on pTZl8-LCB1 gene

each codon of the nucleotide sequence (FIG. 2) beginning
with the ?rst ATG codon at position +1 and ending with the
stop codon TAA at position +1675. Assuming that this ATG
codon is the true translation initiation site, the product of the
open reading frame is a protein of 558 amino acids. Since the
amino terminus of the LCB1 protein has not been deter
mined directly it is possible that the amino terminus of the
actual protein is di?ierent than indicated in FIG. 2. The
difference could occur either because of post-translational
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1986. Eur: J. Biochem. l56:5ll—519), mouse (ALSM (SEQ
ID NO.: 10), FIG. 3, Schoenhaut, D. S., and Curtis, P. J.
1986. Gene 48:55—63) and chicken (ALSC (SEQ ID NO.:
11), FIG. 3, Riddle, R. D., Yamarnoto, M., and Engel, J. D.
1989. Proc. Natl. Acad. Sci. USA. 86:792-796). The pre
dicted LCB1 protein also shows high similarity to the
Escherichia coli enzymes 2-amino-3-ketobutyrate CoA
ligase (EKBL (SEQ ID NO.: 8), FIG. 3, Aronson, B. A.,
Ravnikar, P. D., and Somerville, R. L. 1988. Nucleic Acids
Res. 16:3586) and biotin synthetase (EBIO, FIG. 3, Otsuka,
A. J., Buoncristiani, M. R., Howard, P. K., Flamm, J.,

Johnson, C., Yamarnoto, R., Uchida, K., Cook, C., Ruppet,
J.,

and

Matsuzaki,

J.

1988.

J.

Biol.

Chem.

263:19577—19585).
The similarity of the LCB1 protein to ALA synthase and

claim that LCB1 encodes the SPT enzyme or a subunit of the
to 2-amino-3-ketobutyrate CoA ligase seems particularly
enzyme.
65 signi?cant since these enzymes catalyze a reaction (FIG. 4)

Based upon the results of the lcbl::URA3 disruption
experiments a region surrounding the Sall site shown in FIG.

that is very similar to that catalyzed by SPT. In addition, the
E. coli 2-amino-3-ketobutyrate CoA ligase uses pyridoxal
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phosphate as a cofactor (Mukherjee, J. J., Dekker, E. E.
1987. J. Biol. Chem. 262:14441-14447) as do serine palmi
toyltransferase (Brady, R. O. and Koval, G. J. 1957. J. Am.

Chem. Soc. 79:2648—2649) and ALA synthase (Wamich, G.
R., and Bumham, B. F. 1971. J. Biol. Chem.
246:6880-6885). The similarity of the amino acid sequences

The predicted sequence of the LCB2 protein is shown in
FIG. 6. The protein contains 561 amino acid residues. Since
the amino terminus of the LCB2 protein has not been
determined directly it is possible that the amino terminus of
the actual protein is different than indicated in FIG. 6. The
difference could occur either because of post-translational

(FIG. 3) and the reactions catalyzed by these enzymes (FIG.

processing or because an ATG codon down stream of the one

4) argue that the product of LCBl is most likely SPT or a
catalytic subunit of the enzyme, rather than a regulatory
protein that regulates transcription of LCBl or the enzy
matic activity of SPT.
Besides lcbl-mutant strains, lcb2-mutant strains also lack

shown in FIG. 6 is used as the initiation codon. A membrane

associated helix is predicted for residues 57 to 77 (PYYIS
LLTYLNYLILIILGHV) and 443-463 (LGFIVYGVAD
SPVIPLLLYCP) by the algorithm of Eisenberg et al.,

(1984).

SPT enzyme activity (Pinto, W. 1., Wells, G. W., and Lester,

Comparison of the LCB2 protein sequence against other

R. L. 1992. J. Baterial. 17412575-2581). The LCB2 gene

sequences in GenBank using the FASTA search procedure of

was isolated from a S. cerevisiae genomic DNA library of

Pearson, W. R. and Lipman, D. J ., 1988, Proc. Natl. Acad.
Sci. U.S.A. 85:2444-2448 revealed that the sequence was

complementation for growth on medium lacking phytosph
ingosine of the lcb2 mutation carried in strain B8238. The

homologous to the LCBl protein and to various ALA

strain was transformed with the same recombinant DNA

synthases including the one from S. cerevisiae (FIG. 7). In

library that was used for isolation of LCB1. Ura“ transfor
mants were selected, pooled, and replated on plates lacking
phytosphingosine to select transforrnants that could grow in
the absence of phytosphingosine (Lcb+). Plasmid DNA was
recovered from Lcb+ cells by transformation into E. coli.
Plasmid DNA isolated from E. coli was analyzed by restric~

addition, the sequence was homologuos to the BAC

BIOXWF (Genbank) and the ECOKBLTDH (Genbank,
called EKBL (SEQ ID NO.: 8) in FIG. 3) sequences (data
not shown).
The similarity of the LCB2 protein to the ALA synthases

and to 2-amino-3-ketobutyrate CoA ligase (EKBL FIG. 3,
ECOKBLTDH Gen Bank) seems particularly signi?cant

tion digestion. The pattern of restriction fragments indicated
that all plasmids carried the same insert of about 7-kb which

since these enzymes catalyze a reaction (FIG. 4) that is very
similar to that catalyzed by SPT. In addition, the E. coli

we designated B7 (FIG. 5).
LCB2 was localized by subcloning and testing the sub
clones for their ability to complement the lcb2 mutation in
strain B8238 and allow the strain to grow in the absence of

2-amino-3-ketobutyrate CoA ligase uses pyridoxal phos
phate as a cofactor (Mukherjee and Dekker, 1987) as do

phytosphingosine (EXAMPLE 4). These data localized the

serine palmitoyltransferase and ALA synthase. The similar
ity of the amino acid sequences (FIG. 6) and the reactions

LCB2 gene to a region near the Apal site shown in FIG. 1.
DNA around this site was sequenced and the sequence was

catalyzed by these enzymes (FIG. 4) argue that the product

30

of LCB2 is most likely SPT or a catalytic subunit of the
enzyme, rather than a regulatory protein that regulates
transcription of LCB2 or the enzymatic activity of SPT.

scanned by computer in all reading frames. There was only
one large open reading frame, indicated by the open box at
the top of FIG. 5. The determined DNA sequence and the

Potential uses of the LCBl and LCB2 genes.
One use of the genes is to construct strains of S. cerevisiae

translated open reading frame representing the putative
LCB2 protein are indicated in FIG. 6.
To prove that this open reading was the LCB2 gene we
used the cloned gene to make a chromosomal deletion allele
lcb2A3tzURA3 (EXAMPLE 5), as shown in FIG. 5. The

or other organisms or cell lines that can be used to screen for

inhibitors of SPT enzyme activity or inhibitors of expression
of the LCBl or LCB2 gene at the transcriptional or trans
lational level. To construct a strain for screening inhibitors
of SPT activity, one can use the LCBl and LCB2 genes to

deletion allele was originally introduced into the diploid
strain YPH501 and Southern blotting was used to verify that

overproduce their protein product. Overproduction will

the deletion strain carried one normal allele and the deletion

allele (data not shown). The diploid was sporulated and
spores were tested for their Lcb phenotype. All 17 four
spored tetrads showed 2:2 segregation for the Lcb+:Lcb_
phenotype and all the Lcb- spores were Ura‘“ as expected for
a URA3 gene disruption. Thus, the deleted region is needed
for long-chain base synthesis as would be expected if the
region was the LCB2 gene. To verify that the putative LCB2
gene indicated in FIG. 5 is allelic to the authentic LCB2
gene, we used the integrating vector pRSLCB2-2
(EXAMPLES 6 and FIG. 5) which only carries the 5' half of
the putative LCB2 gene. The plasmid was directed, by
digestion with NaiI, to integrate into the genome of strain
B5238 (relevant genotype lcb2), at the homologuos NsiI site
located in the putative LCB2 gene. Integration at the correct
chromosomal location was veri?ed by Southern blotting

45

(data not shown). The strain carrying the integrated plasmid

60

was crossed to strain YPH-SOO, diploids were selected, and

sporulated. Twenty»?ve four-spored tetrads gave 2 Lcb’“:2

yield a host organism relatively more resistant to SPT
inhibitors compared to a host that does not overproduce the
proteins. This principle was ?rst demonstrated in S. cerevi
siae by Rine, J ., Hansen, W., Hardeman, E., and Davis, R.
W. 1983. Proc. Natl. Acad. Sci. U.S.A. 80:6750-6754. In the
case of an inhibitor of transcription or translation, for

example a triple helix-forming oligonucleotide or an anti
sense koligonucleotide, one can construct a strain carrying

multiple copies of the LCBl and LCB2 genes. Multiple
copies should make the strain more resistant to the inhibitor
than a strain having only one copy of each gene. A variation
55 of this approach could be used for inhibitors of translation

(an antisense oligonucleotide) in which the LCBl and LCB2
coding regions would be fused to a strong promoter-en
hancer region so that a single copy of the fusion genes would
give high levels of LCBl and LCB2 mRNA.
Another use of the LCBl and LCB2 genes is to overex

press them and overproduce their protein product. Such
overproduction usually makes it possible to purify the
proteins. Expression and overproduction could be achieved
in any number of organisms including E. coli, S. cerevisiae,

Lcb‘ segregation and all of the Lcb+ spores were Leu‘ while
the Lcb+ spores were Leu“. These data demonstrate that the
cloned DNA fragment directs integration at or near the lcb2 65 or insect cells or other hosts for baculovirus vectors. The
allele carried in strain BS238. Taken as a whole the data
demonstrate that the LCB2 gene has been cloned.

puri?ed protein could then be used to identify or design
inhibitors of SPT enzyme activity.

5,583,030
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Finally, the LCBl and LCB2 genes can be used to isolate

accession number M63674. The LCB2 sequence (FIG. 6)
has been deposited in the Gen Bank and given accession

their homologs from other organisms. Homologs can be
isolated by complementation of the lcbl and lcb2 mutation
in appropriate S. cerevisiae host strains such as those pre

number M95669.
Serine palmitoyltransferase activity assays were done as

sented in this application. Alternatively, degenerate primers

described in Buede, R., Rinker~Schaifer, C., Pinto, W. 1.,

for the polymerase chain reaction (PCR) could be designed

Lester, R. L., and Dickson, R. C. 1991. J. Bacteriol.
173:4325—4332.
Miscellaneous Procedures—Yeast were transformed by

based upon the sequence of LCBl and LCB2 and used to
prime a PCR reaction using genomic or cDNA from the
organism whose LCB genes are to be cloned. LCBl and

the lithium acetate procedure described by Sherman, F.,
Fink, G. R., and Hicks, T. B. 1986. Methods in Yeasts

LCB2 homologs from particular organisms would enable the
design of highly speci?c triple~helix forming or antisense
oligonucleotides or for inhibitors of SPT activity unique to
a particular organism.

Genetics, Cold Spring Harbor Laboratory, Cold Spring
Harbor, NY. Genetic crosses and tetrad analysis were done

by standard procedures (ibid). Southern blots were done
essentially as described by Maniatis, T., Fritsch, E. F., and

In the examples the following materials were used:
S. cerevisiae: The original lcb mutant MC6A (MATa
lcbl-l inol; Wells and Lester, 1983), was crossed with strain

Sarnbrook, J. 1982. Molecular Cloning: A Laboratory
Manual, Cold Spring Harbor Laboratory, Cold Spring Har
bor, N.Y. For Southern blots [32P]dATP-labeled probes were
prepared by the method of Feinberg, A. P., and Vogelstein,

W303-1B (MATa ade2-l canl-lOO ura3-l his3-11,15 trpl-l
leu2-3,ll2; obtained from R. J. Rothstein, Columbia, Univ.).
Progeny from this cross were backcrossed to W303-1B and

several offspring were selected for further study including
strains X2A1B (MATa lcbl-l ura3-1 trpl-l his3-11,15) and

24D5 (MATot lcbl-l ura3-1 trpl-l leu2-3,ll2 his3-l1,l5).
Strains YPH 1(MATa ura3-52 lys2-80l ade2-10l,), YPH500
(MATa ura3-52 leu2-80l“”'b" leu2-A101”""e trp1-A63 his3
A20 leu2-A1), and YPHSOl (MATa/a ura3-52 leu2-801“'""'“”

B. 1983. Anal. Biochem. 13226-13.
20

EXAMPLE 1

The plasmid pLCB (FIG. 1) was isolated from a S.
cerevisiae genomic DNA library carried in a vector contain
ing the CEN3 region of S. cerevisiae DNA. The 6.44 kb
25

vector was pBR322 with a 0.63 kb Sau3A CEN3 DNA
fragment inserted into the PvuII site of the vector and a 1.4

leu2-101"""e trpl-A63 his3A20 leu2-d1 , were obtained from

Sikorski, R. S. and Hieter, P., 1989, Genetics, 122:19-27.
Strain BS238 (MATa lcb2 ura3-52 leu2~3,112 adel) was
from Pinto, W. J ., Srinivasan, B., Shepherd, 8., Schmidt, A.,
Dickson, R. C., and Lester, R. L. 1992. J. Bacteriol.
174:2565—2574. Strain SJ21R (MATa ura3-52 leu2-3,112
adel MELl) was described in Dickson, R. C., Wells, G. B.,
Schmidt, A., and Lester, R. L. 1990. Mol. Cell. Biol.
10:2176—2l81. The YPH strains are sensitive to the long
chain base phytosphingosine and in order to transform them
with DNA it is necessary to use 12.5 |.1M phytosphingosine
and 0.025% tergitol (half of the normal concentrations) in

kb TRPlARSl fragment inserted into the EcoRI site of the
vector. These ligations were done with molecules whose
ends were made blunt-ended so that the original restriction
30

sites were destroyed. Sau3A genomic DNA fragments of 8
kb average size from strain X2180 (a/a gal2/gal2) were
cloned into the BamHI site of the vector (the library was a

gift from Zymogenetics, Seattle, Wash.) To construct
35

152:481—504).

selection plates. Likewise, for genetic crosses involving
YPH strains it is necessary to make the same adjustments for

dissection plates (minimal medium, Sherman, F., Fink, G.

YCpSO-LCBI, a 4.7 kb StuI fragment from pLCBl contain~
ing the LCBl region, was subcloned into the NruI site of
YCp50 (Rose, M. D. 1987. Meth. Enzymology.
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EXAMPLE 2

R., and Hicks, T. B. 1986. Methods in Yeasts Genetics, Cold

Strain SL1 as derived from strain SJ21R by replacement

Spring Harbor Laboratory, Cold Spring Harbor, N. Y.)

of the LCBl allele with a mutant allele that was disrupted by

otherwise spores will not germinate.
Escherichia coli: strain DHSa was used for propagation of

inserting a 1.1 kb URA3 DNA fragment from S. cerevisiae
into the SalI site of LCBl (FIG. 1 shows the SalI site). The
45 lcb1::URA3 -disnrpted allele was prepared by ligating a 4.3

plasmids.
Media: PYED contained 1% peptone, 1% yeast extract,

kb HindHI-StuI fragment, carrying LCBl, derived from
pLCB (FIG. 1) to pTZ18 (Pharrnacia) which had been

2% agar (for plates), 50 mM sodium succinate (pH 5),

inositol (50 mg/l), potassium phosphate monobasic (50
mg/ml), and 2% or 4% glucose. Minimal medium contained
l>< Difco Yeast Nitrogen Base without amino acids, 50 M

cleaved with the restriction endonucleases HindIH and

Smal. The resulting plasmid, pTZlS-LCBI (FIG. 1), was
50

cleaved with SalI and ligated with a 1.1 kb URA3 DNA

sodium succinate (pH 5), 2% glucose, 1.5% agar (for plates),
inositol (50 mg/ml), valine (150 mg/ml), isoleucine (30
mg/ml), threonine (200 mg/ml) and these supplements at 20

fragment having SalI cohesive ends to yield pTZ18

mg/l: adenine sulfate, arginine-HCl, histidine-HCl, leucine,

LCBl::URA3 DNA was cleaved with XbaI and ClaI,

lysine-HCl, methionine, tryptophan, and uracil. One or more
supplements were omitted from minimal medium for selec

tion of yeast transformants. For strains requiring long chain
base the medium was supplemented with 25 M phytosph
ingosine (Sigma, St. Louis, Mo.). A 10X stock solution of
phytosphingosine was prepared by adding 0.25 ml of 100
M phytosphingosine (dissolved in 95% ethanol) to 99.75
ml of a 0.5% solution of tergitol (Sigma, St. Louis, Mo.).

DNA sequencing: Synthetic oligonucleotide primers were
used for dideoxynucleotide sequencing with Sequenase Ver
sion 2.0 DNA Polymerase (USB, Cleveland, Ohio) essen
tially as recommended by the supplier. The LCBl sequence
(FIG. 2) has been deposited in the Gen Bank and given

LCB1::URA3. To replace the LCBl chromosomal allele

with the URA3-disrupted allele, ten micrograms of pTZlS
55

extracted with phenol, phenolzchloroform and chloroform,
and precipitated with ethanol. The DNA was transformed
into strain SJ21R with selection for Ura+ transformants.
Replacement of the LCBl chromosomal allele with the

60

URA3-disrupted allele was veri?ed by Southern blot analy~
sis. Total DNA isolated from SL1 and the non-disrupted
parental strain SJ21R was cleaved with the restriction endo

nucleases Nrul and StuI. Following Southern blot analysis,
the parental strain showed a 4 kb band of hybridization, as
expected, when the blot was probed with a 32P-labeled NruI
65

to StuI DNA probe containing the LCBl region (FIG. 1). If
the lcb1::URA3-disrupted allele had replaced the wild type
allele of LCBl in strain SL1 then the Southern blot of strain
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SL1 should show two bands that hybridize to the 32P~probe
because URA3 contains a Stul cleavage site. The fragments
should be 2.1 kb and 3 kb in length. The Southern blot (data
not shown) contained the two expected bands of hybridiza
tion indicating that strain SL1 carried the lcbl :zURA3

viations for restriction endonucleases are: B, BamHl, C,

Clal: E, EcoRI; H, HindIII; Ha, HpaI; K, Kpnl; P, PstI; S,
SalI; Sa, Sau3A; Sac, Sacl; Sm, Smal; St, StuI; X, Xbal.
FIG. 2

disruption allele.

DNA sequence of LCBl. The nucleotide sequence of the

LCBl gene of S. cervisiae is presented along with the
deduced protein sequence of the 558 amino acids. The
predicted translation start codon is indicated by +1.

EXAMPLE 3

YIpLCB1~1was constructed by inserting TRPl of S. cer
evisiae, as a 1.4 kb Hind IH fragment, into the Hind HI site

of pTZl8-LCB1. YIpLCBl-l was cleaved at its unique
BarnHI site (FIG. 1), located on the 3' side of LCBl, and the

FIG. 3

Comparison of the deduced amino acid sequence of LCBl
to other proteins. The protein sequences of LCBl and the
mouse (ALSM ((SEQ ID. NO.:10)), chicken (ALSC ((SEQ

linear DNA was used to transform strain 24D5 with selec

tion for Ura+ transforrnants. Integration at the expected
chromosomal location was veri?ed by southern blotting.

ID. NO.:11)), and yeast (ALSY ((SEQ ID. NO.:12)) 5-ami
nolevulinic acid synthases were compared using the proce
dure of Pearson and Lipman (1988) and aligned for maxi
mum similarity. The 2-arnino-3-ketobutyrate CoA ligase
(EKBO ((SEQ ID. NO.:8)) and the biotin synthetase (EBIO
((SEQ ID. NO.:7)) sequences were identi?ed and aligned by
using the FASTA algorithm (ibid). Colons (:) represent

Transfonnants were crossed to strain YPHl.

EXAMPLE 4

Plasmids carrying all of or portions of LCB2 (FIG. 2)
were constructed using standard molecular cloning tech
niques as follows. Insert B7 is a 7 kb BarnI-II S. cerevisiae

DNA fragment cloned into the BamHI site of pRS3l5
(Sikorski and Hieter, 1989). Insert B7AS is a 4.9 kb BamI-II
SalI fragment cloned into pRS3l5 at the BamHI-Sall sites of
the polylinker. Insert 2.3 is a 2.3 kb BamHI-SacI fragment
cloned into pRS316 (Sikorski and Hieter, 1989) at the

identity between residues while dots (.) denote conservative

replacements by similar residues. Insertions made during the
alignment optimization process are indicated by dashes (—).
FIG. 4

BamI-II-SacI sites of the polylinker. Insert LCB2-R is a

Comparison of the reactions catalyzed by serinenpalmi

4.3-kb EcoRI fragment made blunt-ended by ?lling in the
ends with the Klenow fragment of DNA polymerase I and
ligated into the Smal site of pRS3l5.

toyltransferase, ALA synthase, and 2-amino-3ketobutyrate
CoA ligase.

EXAMPLE 5

FIG. 5

S. cerevisiae strain LCB25, carrying the lcb2A3::URA3

35

allele (FIG. 5), was derived from strain YPHSOl as follows:

The LCB2-R insert, carried in pIC20R, Marsh, J. L., Er?e,
M. and Wykes, E. J., 1984, Gene 32:481-485, at the EcoRI
site of the polylinker, was cleaved with the restriction
endonucleases Clal and Xbal (FIG. 5), the ends of the

Structure of Plasmids. A restriction map of the 7 kb
BamHI fragment carrying the LCB2 gene is shown at the top
of the ?gure and the approximate location of LCB2 and the
direction of transcription are indicated. Not all of the cutting
sites for a particular restriction endonuclease are indicated.

40

molecules were made blunt by treatment with the Klenow

A. Portions of the region carrying LCB2 were tested for their
ability to complement the Leb- phenotype of an lcb2
defective strain. E. Structure of a deletion allele. C. Struc
ture of the chromosomal insert carried in pRSLCB2-2.

fragment of DNA polymerase I, and the fragment was
ligated to a 1.1 kb URA3 fragment having blunt ends to give
the lcb2A3zzURA3 allele (FIG. 5).

Vector sequences are not shown. Abbreviations for restric
45

EXAMPLE 6

tion endonucleases are: A, ApaI; B, BamHl; C, Clal; E,

EcoRI; Ns, NsiI; Sa, SalI; S, SacI; Sn, SnaBl; Sp, Sspl; X,
Xbal.

The integrating vector pRSLCB2-2 (FIG. 5) was con

structed by cloning a 2.6-kb BamHI-Apal fragment from the
B7 insert into the BamHI-Apal region of the polylinker in

pRS305 (Sikorski and Hieter, 1989). pRS305 carries the

FIG. 6
50

DETAILED DESCRIPTION OF THE FIGURES

DNA sequence of LCB2. The nucleotide sequence of the

LCB2 gene of S. cervisiae is presented along with the
deduced protein sequence of the 561 amino acids. Numbers
on the right side of the ?gure indicate amino acid residues

LEU2 marker gene that was used for selection of transfor
mants in S. cerevisiae strain B8238.

while numbers on the left indicate nucleotides. The A of the
55

predicted ATG initiation codon has been designated as +1.

FIG. 1
FIG. 7

Structure of Plasmids. The plasmid pLCB carrying the
LCBl gene is shown. The approximate location of LCBl is

Comparison of the predicted LCBl ((SEQ ID. NO.:13)

indicated. Not all restriction endonuclease sites are indicated

and LCB2 ((SEQ ID. NO.:14) protein sequences with each

in a given plasmid. The open arrowhead in pTZl8-LCB1

other (identical residues indicated by an asterisk above the
sequence) and with the ALA synthase of S. cervisiae

represents the T7 promoter. DNA sequences are: open box,
S. cerevisiae; TRPl, a marker gene for selection in S
cerevisiae; ARSl, a S. cerevisiae autonomous replication

(HEM1$Yeast ((SEQ ID. NO.:15)). Asterisks below the

copy of the vector in yeast; BLA and TET confer ampicillin

sequence indicate amino acids that are identical in all three
sequences while dots (.) indicate amino acids that are similar
in the three sequences. Dashes (—) indicate gaps in the

and tetracycline resistance in E. coli, respectively. Abbre

sequence introduced to improve alignment.

sequence; CEN3 a centromere for maintenance of a single

65
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The invention now being fully described it will be appar
ent to one of ordinary skill in the art that many changes and
modi?cations can be made thereto without departing from

adapt for various applications such speci?c embodiments
without departing from the generic concept and therefore

the spirit or scope of the invention as set forth therein. The

the meaning and range of equivalents of the disclosed

foregoing description of the speci?c embodiments will so
fully reveal the general nature of the invention that others

terminology employed herein is for the purpose of descrip

can, by applying current knowledge, readily modify and/or

tion only and not of limitation.

such adaptations are intended to be comprehended within
embodiments. It is to be understood that the phraseology or

SEQUENCE LISTING

( I )GENERAL INFORMATION:
( i i i )NUMBER OF SEQUENCES: 15

( 2 ) INFORMATION FOR SEQ ID NO:1:

( i )SEQUENCE CHARACTERISTICS:
(A )LENGTI-I: 333
( B )TYPE: Nucleic Acid

( C ) STRANDEDNESS: single
( D )TOPOLOGY: linear
( i i )MOLECULE TYPE: polynucleoLide
( x i ) SEQUENCE DESCRIPTION: SEQ ID NOzl:
CGCGTATTTT

TTTTTTTTTG

AGGCGCCATG

ATTTCTTACA

CGGTTTCTTT

TTTTTTTCCT

60

TCTTTCCTTC

TTGCTTCTCT

GCTAACAAAT

TTTTCACTCA

TTCTTTTTTA

TAGGGGCATA

120

TTGCTGCGGT

TAACTGTAGT

GAACGAAAGT

AAGATTGAGA

AAATATAGTA

CTTAAGAAAA

180

AGAAAAGGAA

AAATAAAAAA

AATTCTTTTC

AACATCATCG

AGTAGCACAG

TATAAGAGCG

240

CTCTAACCTT

CTGCCTGGCC

TCCAATATAC

ACATTTTGCT

CGTGTAGGGT

TATTTATCCT

300

TTTTTCTTCC

TTCCCACCCA

AAAAAAAAAA

GCA

333

( 2 ) INFORMATION FOR SEQ ID NO:2:
( i )SEQUENCE CHARACTERISTICS:

(A)I_.ENGTH:I674
( B ) TYPE: nucleic acid

( C ) STRANDEDNESSI single
( D )TOPOLOGY: linear
( i i )MOLECULE TYPE: polypeptide
( x i ) SEQUENCE DESCRIPTION: SEQ ID NO:2:
ATG
MET

GCA
Ala

CAC
His

T
Ile

TTT

ATT

GTT

ACC

Phe

Ile

Val

Thr

CCA
Pro
5

GAG
Glu

GTT
Val

TTA
Leu

ACC

TCA

TCG

TAC

CTA

TGG

TAC

TAC

TTC

AAT

Thr

Ser

Ser

Tyr

Leu

Trp

Tyr

Tyr

Phe

Asn

20

CCC
Pro

AAA
Lys
10

TCA
Ser

T
Ile

CCG
Pro

25

T
Ile

CCG
Pro
I5

GCA
Ala

48

CTG

GTG

96

Leu

Val

30

TTG

ACT

CAA

C

CCG

GGA

GGC

CAA

TTC

C

GTT

TCG

TAC

ATC

AAG

AAA

Leu

Thr

Gln

Ile

Pro

Gly

Gly

Gln

Phc

Ile

Val

Ser

Tyr

Ile

Lys

Lys

35

40

45

TCG

CAT

CAT

GAC

GAT

CCA

TAC

AGG

ACC

ACG

GTT

GAG

ATA

GGG

CTT

T

Ser

His

His

Asp

Asp

Pro

Tyr

Arg

Thr

Thr

Val

Glu

Ilc

Gly

Leu

Ile

50

55

TTA

TAC

GGG

Leu

Tyr

Gly

Ilc

CTT
Leu

TAT

TAC

TTG

TCC

AAG

CCA

CAA

CAG

AAA

AAG

AGT

Ile

Tyr

Tyr

Lcu

Ser

Lys

Pro

Gln

Gln

Lys

Lys

Ser

70
CAA
Gln

GCA
Ala

CAG
Gln

AAG
Lys
85

CCC
Pro

75
AAC
Asn

192

60

ATC

65

I44

CTA
Leu

TCG
Ser

CCC
Pro
9O

CAG
Gln

240

80
GAG
Glu

T
Ile

GAC
Asp

GCG
Ala
95

CTA
Leu

288

336

T

GAG

GAC

TGG

GAG

CCC

GAG

CCT

CTA

GTC

GAC

CCT

TCT

GCC

ACC

GAT

Ile

Glu

Asp

Trp

Glu

Pro

Glu

Pro

Leu

Val

Asp

Pro

Ser

Ala

Thr

Asp

